Data from Moderna and Merck skin cancer Phase 2 trials shows an “extremely strong result” for a personalised cancer vaccine. Photo: Shutterstock Images
Data from Moderna and Merck skin cancer Phase 2 trials shows an “extremely strong result” for a personalised cancer vaccine. Photo: Shutterstock Images
Science

Moderna’s personalised mRNA cancer vaccine shows promise for next phase of trials

  • Data from Moderna, Merck skin cancer Phase 2 trials shows ‘extremely strong result’
  • Company says Hong Kong could play a role in future mRNA vaccine development

Data from Moderna and Merck skin cancer Phase 2 trials shows an “extremely strong result” for a personalised cancer vaccine. Photo: Shutterstock Images
Data from Moderna and Merck skin cancer Phase 2 trials shows an “extremely strong result” for a personalised cancer vaccine. Photo: Shutterstock Images
READ FULL ARTICLE